Go to contents
Go to menu

SITE LINK

Gut and Liver Search Results : 20

SELECT ALL


1 CD40 Agonists Alter the Pancreatic Cancer Microenvironment by Shifting the Macrophage Phenotype towa... Lim Chae-Yoon Chang Jae-Hyuck, Lee Won-Sun, Kim Jea-Na, Park Il-Young Gut and Liver 2022 Volume.16 No.4 645 ~ 659
2 Diagnostic Concordance and Preoperative Risk Factors for Malignancy in Pancreatic Mucinous Cystic Ne... Kim Ga-Hee Choi Kyu, Paik Nam-Young, Lee Kyu-Taek, Lee Jong-Kyun, Lee Kwang-Hyuck, Han In-Woong, Kang... Gut and Liver 2022 Volume.16 No.4 637 ~ 644
3 Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-... Lee Jee-Hyung Kim Hae-Ryoung, Lee Sang-Hyub, Ku Ja-Lok, Chun Jung-Won, Seo Ha-Young, Kim Soon-Chan, Paik... Gut and Liver 2022 Volume.16 No.4 625 ~ 636
4 Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Duct... Chung Taek Rhee Hyung-Jin, Shim Hyo-Sup, Yoo Jeong-Eun, Choi Gi-Hong, Kim Hae-Ryoung, Park Young-Nyun Gut and Liver 2022 Volume.16 No.4 613 ~ 624
5 Insulin-Like Growth Factor-1 Receptor Targeted Fluorescent Imaging for Gallbladder Cancer in Orthoto... Choi Jung-Ha Park Jeong-Youp Gut and Liver 2022 Volume.16 No.4 606 ~ 612
6 Utility of Direct Peroral Cholangioscopy Using a Multibending Ultraslim Endoscope for Difficult Comm... Lee Won-Myung Moon Jong-Ho, Lee Yun-Nah, Shin Il-Sang, Lee Tae-Hoon, Yang Jae-Kook, Cha Sang-Woo, Cho Yo... Gut and Liver 2022 Volume.16 No.4 599 ~ 605
7 Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease Jeong Seog-Song Oh Yun-Hwan, Choi Seul-Ggie, Chang Joo-Young, Kim Sung-Min, Son Joung-Sik, Lee Gyeong-Sil, ... Gut and Liver 2022 Volume.16 No.4 589 ~ 598
8 Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver by Remodeling the Liv... Yuan Na Li Xiaoyan, Wang Meng, Zhang Zhilin, Qiao Lu, Gao Yamei, Xu Xinjian, Zhi Jie, Li Yang... Gut and Liver 2022 Volume.16 No.4 575 ~ 588
9 Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases ... Ahn Soo-Min Choi Jong-Gi, Ye Byong-Duk, Yang Suk-Kyun, Oh Ji-Seon, Kim Yong-Gil, Lee Chang-Keun, Yoo B... Gut and Liver 2022 Volume.16 No.4 567 ~ 574
10 Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Na... Kim Su-Young Cho Yeon-Seo, Kim Hyun-Soo, Lee Jung-Kuk, Kim Hee-Man, Park Hong-Jun, Kim Hyun-Il, Kim Ji-... Gut and Liver 2022 Volume.16 No.4 555 ~ 566
11 Long-term Outcomes of Additional Endoscopic Treatments for Patients with Positive Lateral Margins af... Kim Tae-Se Min Byung-Hoon, Min Yang-Won, Lee Hyuk, Rhee Poong-Lyul, Kim Jae-J., Lee Jun-Haeng Gut and Liver 2022 Volume.16 No.4 547 ~ 554
12 Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatme... Choi Yoon-Jin Lee Yong-Chan, Kim Jung-Mogg, Kim Jin-Il, Moon Jeong-Seop, Lim Yun-Jeong, Baik Gwang-Ho, S... Gut and Liver 2022 Volume.16 No.4 535 ~ 546
13 Endoscopic Reintervention for Recurrence of Malignant Biliary Obstruction: Developing the Best Strat... Takenaka Mamoru Kudo Masatoshi Gut and Liver 2022 Volume.16 No.4 525 ~ 534
14 Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, a... Wu Jia-Feng Gut and Liver 2022 Volume.16 No.4 515 ~ 524
15 Management of Helicobacter pylori Infection: A Comparison between Korea and the United States Kim Sung-Eun Hwang Joo-Ha Gut and Liver 2022 Volume.16 No.4 503 ~ 514
16 Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor ... Kang Eun-Ae Cheon Jae-Hee Gut and Liver 2022 Volume.16 No.4 501 ~ 502
17 Revolution of Novel Direct Peroral Cholangioscopy: Another Step Beyond Limitations Chantarojanasiri Tanyaporn Gut and Liver 2022 Volume.16 No.4 499 ~ 500
18 Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions Lee Jung-Il Gut and Liver 2022 Volume.16 No.4 497 ~ 498
19 Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Compar... Hwang Sung-Wook Gut and Liver 2022 Volume.16 No.4 495 ~ 496
20 Role of Tegoprazan in Helicobacter pylori Eradication Therapy Lee Jin Gut and Liver 2022 Volume.16 No.4 493 ~ 494

site infomation

Prohibition of Unauthorized Collection of E-mail Addresses, medric.kyung@gmail.com
N4 301, Chungbuk National University, Chungdae-ro 1, Seowon-Gu, Cheongju, Chungbuk 28644, Korea